Table 1.
Ingredient composition and nutrient content of turkey diets (g/100 g, as-fed basis) (presented in Mikulski et al., 2022)
| 1–4 | 5–8 | 9–12 | |
|---|---|---|---|
| Ingredients | |||
| wheat | 37.00 | 45.13 | 46.18 |
| maize | 10.00 | 10.00 | 15.00 |
| soybean meal, 46% CP | 42.65 | 33.95 | 25.75 |
| rapeseed meal full fat 20.7% CP | 4.00 | 5.00 | 6.00 |
| soybean oil | 1.21 | 1.36 | 3.00 |
| sodium bicarbonate | 0.15 | 0.15 | 0.15 |
| sodium chloride | 0.20 | 0.20 | 0.20 |
| limestone | 1.41 | 1.40 | 1.28 |
| monocalcium phosphate | 1.87 | 1.54 | 1.15 |
| L Lysine HCL | 0.52 | 0.45 | 0.44 |
| DL Methionine | 0.32 | 0.21 | 0.21 |
| L-Threonine | 0.14 | 0.08 | 0.11 |
| Ronozyme P | 0.01 | 0.01 | 0.01 |
| Ronozyme WX | 0.02 | 0.02 | 0.02 |
| vitamin-mineral premix1 | 0.50 | 0.50 | 0.50 |
| Calculated nutrient content | |||
| metabolizable energy, kcal/kg | 2750 | 2850 | 3050 |
| crude protein | 26.50 | 23.50 | 20.50 |
| lysine | 1.75 | 1.50 | 1.30 |
| methionine | 0.68 | 0.54 | 0.51 |
| Met + Cys | 1.12 | 0.95 | 0.88 |
| threonine | 1.08 | 0.90 | 0.82 |
| calcium | 1.20 | 1.10 | 0.95 |
| available phosphorus | 0.58 | 0.50 | 0.40 |
| Na | 0.14 | 0.14 | 0.14 |
| Analyzed chemical composition | |||
| dry matter | 89.09 | 89.56 | 88.43 |
| crude protein | 26.59 | 24.16 | 21.49 |
| crude fat | 4.42 | 5.41 | 6.82 |
1 Provided per kg diet (feeding periods: weeks 0–4, 5–8, 9–12): mg: retinol 3.78, 3.38 and 2.88, cholecalciferol 0.13, 0.12 and 0.10, α-tocopheryl acetate 100, 90 and 80, vit. K3 5.8, 5.6 and 4.8, thiamine 5.4, 4.7 and 4.0, riboflavin 8.4, 7.5 and 6.4, pyridoxine 6.4, 5.6 and 4.8, cobalamin 0.032, 0.028 and 0.024, biotin 0.32, 0.28 and 0.24, pantothenic acid 28, 24 and 20, nicotinic acid 84, 75 and 64, folic acid 3.2, 2.8 and 2.4, Fe 64, 60, 56 and 48, Mn 120, 112 and 96, Zn 110, 103 and 88, Cu 23, 19 and 16, I 3.2, 2.8 and 2.4, Se 0.30, 0.28 and 0.24, respectively.
Table 2.
Experiment scheme
| CON (without antibiotic) | ENR (enrofloxacin) | DOX (doxycycline) | ||
|---|---|---|---|---|
| Monensin | − (without) | CON− | ENR− | DOX− |
| + (present) | CON+ | ENR+ | DOX+ |
[i] CON− = group without monensin and receiving no antibiotics; CON+ = group with monensin and receiving no antibiotics; ENR− = group without monensin and receiving enrofloxacin; ENR+ = group with monensin and receiving enrofloxacin; DOX− = group without monensin and receiving doxycycline; DOX+ = group with monensin and receiving doxycycline.
Table 3.
Primer sequences and their corresponding Tm values
| Target | Sequence (5′→3′) | Tm (°C) |
|---|---|---|
| GAPDH | CCCTGAGCTCAATGGGAAGC | 55.9 |
| TCAGCAGCAGCCTTCACTAC | 53.8 | |
| ACTB | TACCCCATTGAACACGGCAT | 51.8 |
| CTCCTCAGGGGCTACTCTCA | 55.9 | |
| 18S rRNA | CGAAAGCATTTGCCAAGAAT | 47.7 |
| GGCATCGTTTATGGTCGG | 50.3 | |
| IgY | GAATGGTTGGTGGACGGAGT | 53.8 |
| GCATCCCTTGACGTGATCCT | 53.8 | |
| IFN-gamma | CTGACAAGTCAAAGCCGCAC | 53.8 |
| AGTCATTCATCTGAAGCTTGGC | 53.0 | |
| IL-6 | AAGGCGTGGATAGAGAAG | 48.0 |
| TGACAGATCGGTAACAGAG | 48.9 |
Table 4.
Growth performance parameters of turkeys (from 1 to 85 days of life)
| Item | n | BW 1d, g | BW 85d, kg | BWG, kg | DBWG, g | DFI, g | FCR, kg/kg | Bird mortality/% |
|---|---|---|---|---|---|---|---|---|
| Antibiotic1 | ||||||||
| CON | 16 | 60.8 | 8.045 | 7.984 | 90.2 | 187.7 | 2.081 | 0 / 0.0 |
| ENR | 16 | 60.9 | 8.174 | 8.113 | 91.5 | 192.8 | 2.109 | 11 /2.5 |
| DOX | 16 | 60.7 | 8.226 | 8.166 | 92.5 | 192.8 | 2.085 | 2 / 0.4 |
| Monensin2 | ||||||||
| − | 24 | 60.9 | 8.129 | 8.068 | 91.0 | 192.4 | 2.115 a | 8 / 1.2 |
| + | 24 | 60.8 | 8.168 | 8.107 | 91.8 | 189.8 | 2.069 b | 5 / 0.7 |
| Group | ||||||||
| CON− | 8 | 60.8 | 8.015 | 7.955 | 89.8 | 189.5 | 2.110 | 0 / 0.0 |
| CON+ | 8 | 60.8 | 8.074 | 8.013 | 90.5 | 185.9 | 2.053 | 0 / 0.0 |
| ENR− | 8 | 61.2 | 8.206 | 8.145 | 91.5 | 195.7 | 2.141 | 6 / 2.7 |
| ENR+ | 8 | 60.7 | 8.143 | 8.082 | 91.4 | 189.8 | 2.077 | 5 / 2.2 |
| DOX− | 8 | 60.7 | 8.166 | 8.106 | 91.6 | 191.9 | 2.094 | 2 / 0.9 |
| DOX+ | 8 | 60.8 | 8.287 | 8.226 | 93.3 | 193.6 | 2.077 | 0 / 0.0 |
| SEM | 0.139 | 0.040 | 0.040 | 0.492 | 1.060 | 0.007 | ||
| P value | ||||||||
| antibiotic (A) | 0.895 | 0.183 | 0.182 | 0.181 | 0.073 | 0.205 | NA | |
| monensin (M) | 0.670 | 0.637 | 0.636 | 0.440 | 0.204 | 0.001 | NA | |
| A × M interaction | 0.624 | 0.648 | 0.649 | 0.778 | 0.286 | 0.309 | NA |
1 Treatment: CON, untreated control; MON, treated with monensin at a dose rate of 90 mg/kg feed for 56 days; ENR, treated with enrofloxacin via drinking water at a dose rate of 10 mg/kg BW for the first 5 days of life; DOX, treated with doxycycline via drinking water at a dose rate of 50 mg/kg BW for the first 5 days of life.
Table 5.
Body weight (BW) of turkeys, total yolk sac weight (TYS), and relative yolk sac weight (RYS) at 1, 3 and 5 days of life
| Item | n | Day 1 | Day 3 | Day 5 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| BW, g | TYS, g | RYS, % of BW | BW, g | TYS, g | RYS, % of BW | BW, g | TYS, g | RYS, % of BW | ||
| Antibiotic1 | ||||||||||
| CON | 48 | 71.02 | 2.67 | 3.75 | 91.15 | 0.97 | 1.07 | 117.8 | 0.26 | 0.23 |
| ENR | 48 | 67.53 | 2.74 | 4.05 | 91.24 | 0.89 | 0.98 | 117.8 | 0.25 | 0.22 |
| DOX | 48 | 69.40 | 2.79 | 4.06 | 92.79 | 0.81 | 0.88 | 114.4 | 0.21 | 0.18 |
| Monensin2 | ||||||||||
| − | 72 | 70.36 | 2.73 | 3.91 | 93.56 a | 0.86 | 0.93 | 116.1 | 0.24 | 0.21 |
| + | 72 | 68.28 | 2.73 | 4.00 | 89.90 b | 0.92 | 1.02 | 117.3 | 0.24 | 0.21 |
| Group | ||||||||||
| CON− | 24 | 71.65 | 2.62 | 3.65 | 92.05 | 0.86 | 0.94 | 116.2 | 0.25 | 0.23 |
| CON+ | 24 | 70.39 | 2.73 | 3.86 | 90.25 | 1.08 | 1.20 | 119.5 | 0.27 | 0.23 |
| ENR− | 24 | 69.87 | 2.98 | 4.27 | 94.89 | 0.96 | 1.02 | 118.0 | 0.24 | 0.21 |
| ENR+ | 24 | 65.20 | 2.50 | 3.83 | 87.59 | 0.82 | 0.94 | 117.6 | 0.26 | 0.23 |
| DOX− | 24 | 69.56 | 2.61 | 3.81 | 93.75 | 0.76 | 0.83 | 114.1 | 0.23 | 0.20 |
| DOX+ | 24 | 69.24 | 2.96 | 4.32 | 91.84 | 0.86 | 0.93 | 114.8 | 0.18 | 0.16 |
| SEM | 0.596 | 0.010 | 0.147 | 0.720 | 0.036 | 0.039 | 1.130 | 0.031 | 0.028 | |
| P value | ||||||||||
| antibiotic (A) | 0.053 | 0.895 | 0.677 | 0.565 | 0.180 | 0.174 | 0.379 | 0.760 | 0.884 | |
| monensin (M) | 0.075 | 0.991 | 0.791 | 0.010 | 0.409 | 0.260 | 0.587 | 0.993 | 0.798 | |
| A × M interaction | 0.279 | 0.224 | 0.336 | 0.194 | 0.096 | 0.276 | 0.789 | 0.853 | 0.844 | |
Relative sac weight percentage values were subjected to the Bliss (arc sine) transformation for statistical comparisons. The tables present the original mean and the pooled standard error of the mean (SEM).
1 Treatment: CON, untreated control; MON, treated with monensin at a dose rate of 90 mg/kg feed for 56 days; ENR, treated with enrofloxacin via drinking water at a dose rate of 10 mg/kg BW for the first 5 days of life; DOX, treated with doxycycline via drinking water at a dose rate of 50 mg/kg BW for the first 5 days of life.
Table 6.
Anti-aMPV (TRT) antibody titers in the yolk sac (at 1, 3 and 5 days of life) and blood serum (at 1, 3, 5, 7 and 56 days of life) of turkeys
| Item | n | Yolk sac | Blood serum | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 1d | 3d | 5d | 1d | 3d | 5d | 7d | 56d | ||
| Antibiotic1 | |||||||||
| CON | 48 | 1101.3 | 179.8 | 132.22 | 3446.4 | 2024.1 | 2228.8 | 1006.2 | 239.5 |
| ENR | 48 | 1174.8 | 169.1 | 233.32 | 3624.5 | 1558.4 | 1954.2 | 1437.4 | 154.5 |
| DOX | 48 | 858.0 | 222.6 | 54.12 | 3345.9 | 1363.5 | 1810.9 | 1956.9 | 117.3 |
| Monensin2 | |||||||||
| − | 72 | 1119.1 | 230.9 | 203.22 | 3247.3 | 1689.2 | 2431.2 a | 1615.5 | 207.5 |
| + | 72 | 970.3 | 150.1 | 76.56 | 3697.2 | 1608.2 | 1564.8 b | 1318.2 | 133.4 |
| Group | |||||||||
| CON− | 24 | 997.9 | 112.7 | 191.82 | 3051.9 | 1977.2 | 2415.3 | 1281.4 | 284.7 |
| CON+ | 24 | 1204.6 | 246.9 | 72.61 | 3840.9 | 2071.0 | 2042.3 | 731.0 | 194.3 |
| ENR− | 24 | 1381.2 | 246.8 | 320.54 | 4219.5 | 1531.7 | 2446.8 | 1106.6 | 197.8 |
| ENR+ | 24 | 968.4 | 91.44 | 146.09 | 3029.6 | 1585.1 | 1461.6 | 1768.3 | 111.2 |
| DOX− | 24 | 978.2 | 333.1 | 97.29 | 2470.7 | 1558.6 | 2431.3 | 2458.5 | 139.9 |
| DOX+ | 24 | 737.8 | 112.0 | 10.96 | 4221.1 | 1168.4 | 1190.5 | 1455.3 | 94.63 |
| SEM | 121.9 | 37.46 | 37.02 | 299.8 | 159.7 | 192.6 | 196.2 | 39.82 | |
| P value | |||||||||
| antibiotic (A) | 0.546 | 0.826 | 0.140 | 0.929 | 0.229 | 0.664 | 0.139 | 0.409 | |
| monensin (M) | 0.546 | 0.282 | 0.087 | 0.455 | 0.801 | 0.025 | 0.445 | 0.333 | |
| A × M interaction | 0.570 | 0.122 | 0.885 | 0.129 | 0.792 | 0.637 | 0.198 | 0.965 | |
1 Treatment: CON, untreated control; MON, treated with monensin at a dose rate of 90 mg/kg feed for 56 days; ENR, treated with enrofloxacin via drinking water at a dose rate of 10 mg/kg BW for the first 5 days of life; DOX, treated with doxycycline via drinking water at a dose rate of 50 mg/kg BW for the first 5 days of life.
Table 7.
Anti-NDV antibody titers in the yolk sac (at 1, 3 and 5 days of life) and blood serum (at 1, 3, 5, 7 and 56 days of life) of turkeys
| Item | n | Yolk sac | Blood serum | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 1d | 3d | 5d | 1d | 3d | 5d | 7d | 56d | ||
| Antibiotic1 | |||||||||
| CON | 48 | 262.4 | 144.75 | 61.81 | 967.4 | 798.8 | 1221.5 | 462.9 | 283.3 |
| ENR | 48 | 537.5 | 66.66 | 46.46 | 1267.6 | 528.4 | 915.4 | 655.3 | 303.0 |
| DOX | 48 | 264.9 | 61.21 | 49.38 | 1123.8 | 526.6 | 1028.8 | 670.9 | 376.1 |
| Monensin2 | |||||||||
| − | 72 | 274.2 | 105.92 | 84.15 a | 1064.8 | 666.2 | 1217.1 | 647.9 | 373.8 a |
| + | 72 | 435.6 | 75.83 | 20.95 b | 1174.4 | 569.6 | 893.3 | 544.9 | 267.8 b |
| Group | |||||||||
| CON− | 24 | 152.2 | 150.54 | 93.17 | 942.5 | 776.3 | 1287.0 | 456.6 | 335.3 |
| CON+ | 24 | 372.6 | 138.97 | 30.45 | 992.3 | 821.2 | 1156.0 | 469.3 | 231.3 |
| ENR− | 24 | 410.5 | 96.17 | 63.63 | 1418.4 | 705.6 | 1001.8 | 770.4 | 335.8 |
| ENR+ | 24 | 664.5 | 37.15 | 29.29 | 1116.7 | 351.2 | 829.0 | 540.3 | 270.3 |
| DOX− | 24 | 260.0 | 71.05 | 95.65 | 833.3 | 516.6 | 1362.6 | 716.8 | 450.4 |
| DOX+ | 24 | 269.9 | 51.36 | 3.10 | 1414.3 | 536.5 | 695.0 | 625.1 | 301.7 |
| SEM | 64.17 | 17.99 | 14.65 | 100.8 | 69.63 | 108.1 | 69.44 | 27.01 | |
| P value | |||||||||
| antibiotic (A) | 0.134 | 0.108 | 0.902 | 0.479 | 0.188 | 0.507 | 0.403 | 0.335 | |
| monensin (M) | 0.208 | 0.404 | 0.032 | 0.587 | 0.488 | 0.137 | 0.463 | 0.049 | |
| A × M interaction | 0.700 | 0.847 | 0.719 | 0.202 | 0.424 | 0.532 | 0.777 | 0.819 | |
1 Treatment: CON, untreated control; MON, treated with monensin at a dose rate of 90 mg/kg feed for 56 days; ENR, treated with enrofloxacin via drinking water at a dose rate of 10 mg/kg BW for the first 5 days of life; DOX, treated with doxycycline via drinking water at a dose rate of 50 mg/kg BW for the first 5 days of life.
Table 8.
Anti-ORT antibody titers in the yolk sac (at 1, 3 and 5 days of life) and blood serum (at 1, 3, 5, 7 and 56 days of life) of turkeys
| Item | n | Yolk sac | Blood serum | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 1d | 3d | 5d | 1d | 3d | 5d | 7d | 56d | ||
| Antibiotic1 | |||||||||
| CON | 48 | 459.2 | 179.0 | 119.14 | 2991.8 b | 2120.4 | 3105.0 | 1455.7 | 17649.8 |
| ENR | 48 | 725.5 | 180.6 | 329.67 | 4597.6 a | 1640.2 | 2535.4 | 915.6 | 18348.9 |
| DOX | 48 | 407.2 | 166.0 | 181.38 | 3480.1 ab | 1878.7 | 2664.0 | 1191.5 | 17759.8 |
| Monensin2 | |||||||||
| − | 72 | 491.9 | 163.1 | 178.72 | 3488.0 | 2081.7 | 3303.3 a | 1359.4 | 18334.7 |
| + | 72 | 569.4 | 187.3 | 241.41 | 3891.6 | 1677.8 | 2233.0 b | 1015.8 | 17504.4 |
| Group | |||||||||
| CON− | 24 | 500.6 | 201.4 | 164.60 b | 3464.4 | 2523.7 | 3284.7 | 1465.3 | 19110.2 |
| CON+ | 24 | 417.8 | 156.5 | 73.67 b | 2519.2 | 1717.0 | 2925.4 | 1446.0 | 16189.4 |
| ENR− | 24 | 726.1 | 216.7 | 84.06 b | 4025.9 | 1935.0 | 3263.3 | 1047.6 | 17867.9 |
| ENR+ | 24 | 724.9 | 144.5 | 575.28 a | 5169.2 | 1345.4 | 1807.6 | 783.7 | 18830.0 |
| DOX− | 24 | 248.9 | 71.18 | 287.49 ab | 2973.8 | 1786.5 | 3362.1 | 1565.2 | 18025.9 |
| DOX+ | 24 | 565.4 | 260.8 | 75.27 b | 3986.4 | 1971.0 | 1965.9 | 817.9 | 17493.6 |
| SEM | 75.03 | 38.95 | 55.15 | 262.1 | 158.7 | 233.0 | 108.8 | 540.0 | |
| P value | |||||||||
| antibiotic (A) | 0.182 | 0.986 | 0.266 | 0.035 | 0.469 | 0.573 | 0.126 | 0.853 | |
| monensin (M) | 0.606 | 0.759 | 0.563 | 0.433 | 0.205 | 0.022 | 0.112 | 0.446 | |
| A × M interaction | 0.519 | 0.330 | 0.020 | 0.181 | 0.410 | 0.553 | 0.374 | 0.342 | |
1 Treatment: CON, untreated control; MON, treated with monensin at a dose rate of 90 mg/kg feed for 56 days; ENR, treated with enrofloxacin via drinking water at a dose rate of 10 mg/kg BW for the first 5 days of life; DOX, treated with doxycycline via drinking water at a dose rate of 50 mg/kg BW for the first 5 days of life.
Table 9.
Total IgY antibody levels in the yolk sac (at 1, 3 and 5 days of life) and blood serum (at 1, 3, 5, 7 and 56 days of life) of turkeys
| Item | n | Yolk sac (mg/total yolk sac) | Blood serum (mg/mL) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 1d | 3d | 5d | 1d | 3d | 5d | 7d | 56d | ||
| Antibiotic1 | |||||||||
| CON | 48 | 21.16 | 10.079 | 2.953 | 3.282 | 5.621 | 7.594 a | 5.133 b | 5.718 a |
| ENR | 48 | 27.23 | 7.169 | 2.851 | 3.606 | 5.450 | 6.913 ab | 4.760 b | 3.622 b |
| DOX | 48 | 32.02 | 8.548 | 2.147 | 3.865 | 5.958 | 6.524 b | 6.174 a | 2.842 b |
| Monensin2 | |||||||||
| − | 72 | 20.67 b | 7.156 b | 2.527 | 3.190 b | 5.499 | 7.114 | 5.213 | 3.794 |
| + | 72 | 32.93 a | 10.042 a | 2.775 | 3.979 a | 5.854 | 6.907 | 5.498 | 4.328 |
| Group | |||||||||
| CON− | 24 | 16.88 | 6.735 b | 3.365 | 2.839 b | 5.760 | 8.075 | 5.185 | 5.259 |
| CON+ | 24 | 25.43 | 13.424 a | 2.542 | 3.726 | 5.482 | 7.113 | 5.082 | 6.178 |
| ENR− | 24 | 23.41 | 7.046 b | 2.044 | 3.265 | 5.474 | 6.438 | 4.167 | 3.095 |
| ENR+ | 24 | 31.04 | 7.292 b | 3.659 | 3.947 | 5.427 | 7.389 | 5.353 | 4.149 |
| DOX− | 24 | 21.73 | 7.688 b | 2.171 | 3.465 | 5.262 | 6.828 | 6.287 | 3.028 |
| DOX+ | 24 | 42.30 | 9.409 ab | 2.123 | 4.264 | 6.653 | 6.219 | 6.060 | 2.657 |
| SEM | 2.355 | 0.556 | 0.313 | 0.160 | 0.170 | 0.175 | 0.187 | 0.297 | |
| P value | |||||||||
| antibiotic (A) | 0.157 | 0.085 | 0.522 | 0.322 | 0.459 | 0.038 | 0.005 | 0.000 | |
| monensin (M) | 0.009 | 0.007 | 0.693 | 0.014 | 0.294 | 0.546 | 0.432 | 0.345 | |
| A × M interaction | 0.441 | 0.037 | 0.272 | 0.965 | 0.095 | 0.055 | 0.214 | 0.524 | |
1 Treatment: CON, untreated control; MON, treated with monensin at a dose rate of 90 mg/kg feed for 56 days; ENR, treated with enrofloxacin via drinking water at a dose rate of 10 mg/kg BW for the first 5 days of life; DOX, treated with doxycycline via drinking water at a dose rate of 50 mg/kg BW for the first 5 days of life.
Table 10.
Total IgM antibody levels in the yolk sac (at 1, 3 and 5 days of life) and blood serum (at 1, 3, 5, 7 and 56 days of life) of turkeys
| Item | n | Yolk sac (μg/total yolk sac) | Blood serum (μg/mL) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 1d | 3d | 5d | 1d | 3d | 5d | 7d | 56d | ||
| Antibiotic1 | |||||||||
| CON | 48 | 264.1 | 141.07 a | 22.18 | 48.64 | 42.50 a | 72.27 | 61.32 b | 49.45 |
| ENR | 48 | 243.0 | 90.21 b | 24.84 | 33.97 | 40.44 a | 61.32 | 61.57 b | 52.89 |
| DOX | 48 | 239.7 | 97.93 b | 15.09 | 48.69 | 31.53 b | 64.46 | 88.28 ab | 49.40 |
| Monensin2 | |||||||||
| − | 72 | 242.8 | 100.30 | 19.46 | 35.62 b | 44.44 a | 70.15 | 67.77 | 51.98 |
| + | 72 | 255.1 | 119.18 | 21.94 | 51.91 a | 31.87 b | 61.88 | 73.00 | 49.19 |
| Group | |||||||||
| CON− | 24 | 225.5 | 121.68 | 26.79 | 38.59 ab | 47.47 | 75.14 | 59.37 | 51.35 |
| CON+ | 24 | 302.7 | 160.46 | 17.58 | 58.70 ab | 37.52 | 69.41 | 63.27 | 47.56 |
| ENR− | 24 | 266.3 | 93.15 | 17.94 | 36.62 b | 46.51 | 60.14 | 64.49 | 50.97 |
| ENR+ | 24 | 219.6 | 87.27 | 31.73 | 31.33 b | 34.37 | 62.51 | 58.64 | 54.81 |
| DOX− | 24 | 236.4 | 86.06 | 13.67 | 31.66 b | 39.33 | 75.18 | 79.46 | 53.62 |
| DOX+ | 24 | 243.1 | 109.80 | 16.51 | 65.72 a | 23.73 | 53.73 | 97.10 | 45.19 |
| SEM | 12.16 | 6.322 | 2.897 | 3.067 | 1.590 | 3.665 | 3.932 | 1.726 | |
| P value | |||||||||
| antibiotic (A) | 0.674 | 0.001 | 0.368 | 0.062 | 0.006 | 0.457 | 0.005 | 0.643 | |
| monensin (M) | 0.612 | 0.121 | 0.670 | 0.006 | 0.000 | 0.262 | 0.495 | 0.422 | |
| A × M interaction | 0.117 | 0.311 | 0.273 | 0.022 | 0.731 | 0.406 | 0.454 | 0.348 | |
1 Treatment: CON, untreated control; MON, treated with monensin at a dose rate of 90 mg/kg feed for 56 days; ENR, treated with enrofloxacin via drinking water at a dose rate of 10 mg/kg BW for the first 5 days of life; DOX, treated with doxycycline via drinking water at a dose rate of 50 mg/kg BW for the first 5 days of life.
Table 11.
Effects of treatments on immunocompetent organ weights (spleen and bursa of Fabricius) at 7 and 56 days of turkeys' life
| Item | n | 7 days | 56 days | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Body weight, g | Spleen | Bursa of Fabricius | Body weight, g | Spleen | Bursa of Fabricius | ||||||
| total weight, g | relative weight, % of bw | total weight, g | relative weight, % of bw | total weight, g | relative weight, % of bw | total weight, g | relative weight, % of bw | ||||
| Antibiotic1 | |||||||||||
| CON | 16 | 158.7 ab | 0.113 | 0.071 | 0.274 | 0.17 | 4320 | 3.854 | 0.089 | 4.458 | 0.103 |
| ENR | 16 | 168.3 a | 0.124 | 0.074 | 0.307 | 0.18 | 4356 | 3.782 | 0.087 | 4.311 | 0.099 |
| DOX | 16 | 154.4 b | 0.112 | 0.073 | 0.256 | 0.16 | 4274 | 3.952 | 0.092 | 4.296 | 0.101 |
| Monensin2 | |||||||||||
| − | 24 | 165.1 a | 0.116 | 0.070 | 0.300 a | 0.18 | 4316 | 3.634 | 0.084 | 4.496 | 0.104 |
| + | 24 | 155.9 b | 0.117 | 0.075 | 0.258 b | 0.17 | 4317 | 4.091 | 0.095 | 4.215 | 0.097 |
| Group | |||||||||||
| CON− | 8 | 162.9 | 0.106 | 0.065 | 0.284 | 0.17 | 4286 | 3.561 | 0.084 | 4.410 | 0.103 |
| CON+ | 8 | 154.5 | 0.120 | 0.077 | 0.265 | 0.17 | 4354 | 4.146 | 0.095 | 4.507 | 0.104 |
| ENR− | 8 | 175.2 | 0.128 | 0.073 | 0.344 | 0.20 | 4396 | 3.576 | 0.081 | 4.496 | 0.102 |
| ENR+ | 8 | 161.4 | 0.121 | 0.075 | 0.270 | 0.17 | 4316 | 3.989 | 0.093 | 4.126 | 0.095 |
| DOX− | 8 | 157.1 | 0.114 | 0.073 | 0.273 | 0.17 | 4266 | 3.766 | 0.088 | 4.581 | 0.108 |
| DOX+ | 8 | 151.7 | 0.110 | 0.073 | 0.239 | 0.16 | 4281 | 4.137 | 0.096 | 4.011 | 0.093 |
| SEM | 2.209 | 0.006 | 0.003 | 0.010 | 0.005 | 33.21 | 0.121 | 0.003 | 0.109 | 0.002 | |
| P value | |||||||||||
| antibiotic (A) | 0.022 | 0.989 | 0.989 | 0.079 | 0.429 | 0.622 | 0.852 | 0.645 | 0.804 | 0.696 | |
| monensin (M) | 0.028 | 0.555 | 0.555 | 0.026 | 0.112 | 0.990 | 0.070 | 0.071 | 0.211 | 0.177 | |
| A × M interaction | 0.690 | 0.854 | 0.854 | 0.452 | 0.510 | 0.677 | 0.931 | 0.965 | 0.458 | 0.515 | |
Relative spleen and bursa of Fabricius mass percentage values were subjected to the Bliss (arc sine) transformation for statistical comparisons. The tables present the original mean and the pooled standard error of the mean (SEM).
1 Treatment: CON, untreated control; MON, treated with monensin at a dose rate of 90 mg/kg feed for 56 days; ENR, treated with enrofloxacin via drinking water at a dose rate of 10 mg/kg BW for the first 5 days of life; DOX, treated with doxycycline via drinking water at a dose rate of 50 mg/kg BW for the first 5 days of life.
Table 12.
Percentages of T-cell and B-cell subpopulations in the blood of turkeys
| Item | n | 7 days | 56 days | ||||||
|---|---|---|---|---|---|---|---|---|---|
| CD4+ | CD8+ | CD4+CD8+ | IgM+ | CD4+ | CD8+ | CD4+CD8+ | IgM+ | ||
| Antibiotic1 | |||||||||
| CON | 16 | 20.08 | 1.673 | 0.533 | 5.234 | 23.54 a | 2.675 | 0.341 | 7.231 |
| ENR | 16 | 19.01 | 1.442 | 0.573 | 5.144 | 21.71 a | 2.205 | 0.319 | 6.077 |
| DOX | 16 | 21.42 | 1.801 | 0.604 | 5.588 | 15.49 b | 1.807 | 0.240 | 6.039 |
| Monensin2 | |||||||||
| − | 24 | 23.07 a | 1.885 a | 0.594 | 5.304 | 21.13 | 2.396 | 0.308 | 6.789 |
| + | 24 | 17.27 b | 1.393 b | 0.546 | 5.339 | 19.36 | 2.062 | 0.292 | 6.108 |
| Group | |||||||||
| CON− | 8 | 26.51 | 2.103 | 0.514 | 5.041 | 18.80 b | 2.353 ab | 0.290 | 7.091 |
| CON+ | 8 | 13.65 | 1.243 | 0.553 | 5.426 | 28.28 a | 2.998 a | 0.391 | 7.370 |
| ENR− | 8 | 21.35 | 1.493 | 0.660 | 5.041 | 29.34 a | 2.886 a | 0.381 | 7.198 |
| ENR+ | 8 | 16.66 | 1.391 | 0.485 | 5.246 | 14.08 b | 1.524 b | 0.256 | 4.956 |
| DOX− | 8 | 21.35 | 2.059 | 0.609 | 5.830 | 15.26 b | 1.950 ab | 0.253 | 6.079 |
| DOX+ | 8 | 21.49 | 1.544 | 0.600 | 5.345 | 15.73 b | 1.664 b | 0.228 | 5.999 |
| SEM | 1.378 | 0.106 | 0.020 | 0.099 | 1.229 | 0.161 | 0.029 | 0.292 | |
| P value | |||||||||
| antibiotic (A) | 0.756 | 0.339 | 0.325 | 0.148 | 0.001 | 0.064 | 0.354 | 0.155 | |
| monensin (M) | 0.033 | 0.018 | 0.215 | 0.856 | 0.318 | 0.260 | 0.787 | 0.231 | |
| A × M interaction | 0.137 | 0.309 | 0.069 | 0.159 | 0.000 | 0.027 | 0.303 | 0.151 | |
1 Treatment: CON, untreated control; MON, treated with monensin at a dose rate of 90 mg/kg feed for 56 days; ENR, treated with enrofloxacin via drinking water at a dose rate of 10 mg/kg BW for the first 5 days of life; DOX, treated with doxycycline via drinking water at a dose rate of 50 mg/kg BW for the first 5 days of life.
Table 13.
Percentages of T-cell and B-cell subpopulations in the spleen of turkeys
| Item | n | 7 days | 56 days | ||||||
|---|---|---|---|---|---|---|---|---|---|
| CD4+ | CD8+ | CD4+CD8+ | IgM+ | CD4+ | CD8+ | CD4+CD8+ | IgM+ | ||
| Antibiotic1 | |||||||||
| CON | 16 | 43.56 | 13.95 | 1.577 | 8.074 | 36.66 | 19.30 b | 1.917 | 14.27 |
| ENR | 16 | 46.59 | 14.20 | 1.739 | 8.648 | 33.69 | 23.96 a | 2.053 | 15.25 |
| DOX | 16 | 45.93 | 14.40 | 1.740 | 8.626 | 34.20 | 24.04 a | 2.221 | 14.60 |
| Monensin2 | |||||||||
| − | 24 | 46.03 | 14.97 | 1.836 a | 8.293 | 35.50 | 20.75 b | 2.021 | 12.61 b |
| + | 24 | 44.68 | 13.39 | 1.534 b | 8.606 | 34.20 | 24.12 a | 2.106 | 16.80 a |
| Group | |||||||||
| CON− | 8 | 45.71 | 13.76 | 1.735 | 7.394 | 35.00 | 21.14 ab | 2.064 ab | 12.84 |
| CON+ | 8 | 41.41 | 14.14 | 1.419 | 8.754 | 38.31 | 17.46 b | 1.770 b | 15.71 |
| ENR− | 8 | 47.15 | 14.56 | 1.916 | 9.006 | 34.29 | 20.46 b | 2.123 ab | 13.18 |
| ENR+ | 8 | 46.03 | 13.83 | 1.561 | 8.290 | 33.09 | 27.46 a | 1.984 ab | 17.31 |
| DOX− | 8 | 45.24 | 16.59 | 1.858 | 8.478 | 37.20 | 20.65 b | 1.878 b | 11.80 |
| DOX+ | 8 | 46.61 | 12.22 | 1.623 | 8.775 | 31.20 | 27.44 a | 2.565 a | 17.39 |
| SEM | 0.963 | 0.674 | 0.050 | 0.269 | 0.827 | 0.806 | 0.075 | 0.623 | |
| P value | |||||||||
| Antibiotic (A) | 0.421 | 0.964 | 0.253 | 0.626 | 0.275 | 0.004 | 0.208 | 0.774 | |
| Monensin (M) | 0.493 | 0.255 | 0.002 | 0.568 | 0.419 | 0.010 | 0.541 | 0.001 | |
| A × M interaction | 0.499 | 0.342 | 0.860 | 0.309 | 0.068 | 0.001 | 0.013 | 0.621 | |
1 Treatment: CON, untreated control; MON, treated with monensin at a dose rate of 90 mg/kg feed for 56 days; ENR, treated with enrofloxacin via drinking water at a dose rate of 10 mg/kg BW for the first 5 days of life; DOX, treated with doxycycline via drinking water at a dose rate of 50 mg/kg BW for the first 5 days of life.
Table 14.
Immunological parameters in the blood plasma of turkeys at 7 days of life
| Item | n | IgA total, ng/mL | TLR-4, ng/mL | IL-2, ng/mL | IL-4, pg/mL | IL-6, ng/L | IL-8, pg/mL | IL-12, ng/mL | IL-13, pg/mL | IL-1ß, pg/mL | TNFα, g/mL | IFN-γ, pg/mL | NF-kB, ng/mL | CRP, ng/ml |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antibiotic1 | ||||||||||||||
| CON | 16 | 630.0 | 1.506 a | 5.011 | 52.78 ab | 34.46 | 7.578 b | 14.77 b | 20.41 | 66.56 b | 382.1 | 113.19 a | 2.694 | 10.680 a |
| ENR | 16 | 593.5 | 0.847 b | 4.960 | 47.53 b | 36.82 | 8.234 b | 18.66 a | 18.99 | 73.64 ab | 382.2 | 77.70 b | 2.590 | 4.918 b |
| DOX | 16 | 521.6 | 0.900 b | 5.325 | 56.44 a | 38.31 | 11.192 a | 16.60 ab | 19.35 | 87.36 a | 371.7 | 120.59 a | 2.438 | 9.130 a |
| Monensin2 | ||||||||||||||
| − | 24 | 526.4 | 1.279 a | 4.717 | 50.65 | 38.14 | 8.851 | 16.00 | 18.68 | 69.12 | 365.5 | 112.57 a | 2.684 | 9.221 a |
| + | 24 | 637.1 | 0.889 b | 5.481 | 53.85 | 34.91 | 9.152 | 17.35 | 20.48 | 82.59 | 391.8 | 95.08 b | 2.465 | 7.264 b |
| Group | ||||||||||||||
| CON− | 8 | 578.5 | 2.268 a | 4.084 b | 52.07 | 35.41 ab | 7.639 | 13.96 c | 19.79 | 66.38 b | 365.4 | 142.28 a | 3.346 a | 12.520 a |
| CON+ | 8 | 681.6 | 0.744 b | 5.938 ab | 53.48 | 33.50 ab | 7.518 | 15.58 bc | 21.03 | 66.74 b | 398.8 | 84.11 bc | 2.042 b | 8.841 abc |
| ENR− | 8 | 568.3 | 0.807 b | 5.679 ab | 49.36 | 42.61 a | 7.256 | 21.19 a | 18.25 | 70.67 b | 383.8 | 72.01 c | 2.726 ab | 8.236 bc |
| ENR+ | 8 | 618.7 | 0.888 b | 4.241 b | 45.70 | 31.03 b | 9.212 | 16.12 bc | 19.73 | 76.61 b | 380.5 | 83.39 bc | 2.455 ab | 1.599 d |
| DOX− | 8 | 432.5 | 0.764 b | 4.388 b | 50.52 | 36.41 ab | 11.659 | 12.85 c | 18.00 | 70.30 b | 347.2 | 123.42 a | 1.979 b | 6.906 c |
| DOX+ | 8 | 610.8 | 1.036 b | 6.263 a | 62.36 | 40.21 ab | 10.725 | 20.36 ab | 20.69 | 104.42 a | 396.1 | 117.75 ab | 2.897 ab | 11.353 ab |
| SEM | 28.42 | 0.099 | 0.232 | 1.496 | 1.250 | 0.436 | 0.628 | 0.661 | 2.935 | 9.300 | 5.002 | 0.118 | 0.632 | |
| P value | ||||||||||||||
| antibiotic (A) | 0.277 | 0.000 | 0.735 | 0.037 | 0.411 | 0.001 | 0.006 | 0.674 | 0.003 | 0.873 | 0.000 | 0.580 | 0.000 | |
| monensin (M) | 0.052 | 0.004 | 0.070 | 0.249 | 0.177 | 0.695 | 0.152 | 0.189 | 0.006 | 0.170 | 0.018 | 0.280 | 0.016 | |
| A × M interaction | 0.641 | 0.000 | 0.002 | 0.074 | 0.035 | 0.289 | 0.000 | 0.896 | 0.012 | 0.518 | 0.001 | 0.000 | 0.000 |
1 Treatment: CON, untreated control; MON, treated with monensin at a dose rate of 90 mg/kg feed for 56 days; ENR, treated with enrofloxacin via drinking water at a dose rate of 10 mg/kg BW for the first 5 days of life; DOX, treated with doxycycline via drinking water at a dose rate of 50 mg/kg BW for the first 5 days of life.
2 Denotes without monensin − or with monensin +. IgA – immunoglobulin A, TLR-4 – Toll-like receptor 4, IL-2 – interleukin 2, IL-4 – interleukin 4, IL-6 – interleukin 6, IL-8 – interleukin 8, IL-12 – interleukin 12, IL-13 – interleukin 13, IL-1ß – interleukin 1ß, TNFα – tumor necrosis factor α, IFN-γ – interferon γ, NF-kB – nuclear factor kappa light chain, CRP – C-reactive protein.
Table 15.
Immunological parameters in the blood plasma of turkeys at 56 days of life
| Item | n | IgA total, ng/mL | TLR-4, ng/mL | IL-2, ng/mL | IL-4, pg/mL | IL-6, ng/L | IL-8, pg/mL | IL-12, ng/mL | Il-13, pg/mL | IL-1ß, pg/mL | TNFα, pg/mL | IFN-γ, pg/mL | NF-kB, mg/mL | CRP, ng/ml |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antibiotic1 | ||||||||||||||
| CON | 16 | 654.3 | 1.179 | 6.726 y | 82.45 a | 47.35 | 9.694 | 25.93 b | 17.14 | 103.9 | 223.6 a | 46.36 b | 2.806 | 0.821 |
| ENR | 16 | 673.7 | 1.144 | 8.464 x | 83.64 a | 45.20 | 10.583 | 35.55 a | 19.99 | 128.5 | 171.8 b | 52.89 ab | 3.365 | 0.860 |
| DOX | 16 | 779.8 | 1.265 | 8.541 x | 58.00 b | 47.62 | 9.859 | 30.02 ab | 19.09 | 123.7 | 174.7 b | 57.66 a | 2.849 | 0.850 |
| Monensin2 | ||||||||||||||
| − | 24 | 795.6 a | 1.138 | 7.409 | 80.52 a | 44.98 | 8.448 b | 30.37 | 16.84 b | 97.1 b | 199.2 | 42.47 b | 2.457 b | 0.905 |
| + | 24 | 609.6 b | 1.253 | 8.412 | 68.87 b | 48.46 | 11.642 a | 30.63 | 20.64 a | 140.3 a | 180.9 | 62.13 a | 3.556 a | 0.783 |
| Group | ||||||||||||||
| CON− | 8 | 773.2 abc | 0.766 c | 5.868 | 79.69 a | 48.64 | 7.870 | 12.64 b | 11.85 b | 58.3 b | 210.4 a | 21.64 c | 1.725 c | 0.615 b |
| CON+ | 8 | 535.4 bc | 1.593 a | 7.583 | 85.22 a | 46.06 | 11.518 | 39.22 a | 22.44 a | 149.5 a | 236.9 a | 71.07 a | 3.886 a | 1.028 a |
| ENR− | 8 | 843.9 a | 1.303 ab | 8.343 | 91.31 a | 46.46 | 9.562 | 38.88 a | 22.05 a | 114.1 a | 173.4 ab | 46.36 b | 3.335 ab | 1.048 a |
| ENR+ | 8 | 503.4 c | 0.984 bc | 8.586 | 75.97 a | 43.94 | 11.604 | 32.21 a | 17.93 ab | 142.9 a | 170.3 ab | 59.41 ab | 3.394 ab | 0.672 ab |
| DOX− | 8 | 769.6 abc | 1.346 ab | 8.015 | 70.56 ab | 39.83 | 7.913 | 39.58 a | 16.60 ab | 118.8 a | 213.9 a | 59.40 ab | 2.309 bc | 1.050 a |
| DOX+ | 8 | 790.0 ab | 1.183 abc | 9.067 | 45.43 c | 55.40 | 11.805 | 20.45 b | 21.57 a | 128.7 a | 135.6 b | 55.91 ab | 3.388 ab | 0.649 ab |
| SEM | 31.80 | 0.059 | 0.326 | 3.186 | 1.822 | 0.430 | 1.841 | 0.951 | 5.965 | 8.273 | 2.726 | 0.156 | 0.047 | |
| P value | ||||||||||||||
| antibiotic (A) | 0.132 | 0.558 | 0.032 | 0.000 | 0.832 | 0.587 | 0.004 | 0.359 | 0.060 | 0.006 | 0.023 | 0.114 | 0.916 | |
| monensin (M) | 0.001 | 0.225 | 0.109 | 0.025 | 0.334 | 0.000 | 0.907 | 0.025 | 0.000 | 0.202 | 0.000 | 0.000 | 0.126 | |
| A × M interaction | 0.025 | 0.000 | 0.620 | 0.048 | 0.068 | 0.549 | 0.000 | 0.003 | 0.001 | 0.012 | 0.000 | 0.003 | 0.000 |
1 Treatment: CON, untreated control; MON, treated with monensin at a dose rate of 90 mg/kg feed for 56 days; ENR, treated with enrofloxacin via drinking water at a dose rate of 10 mg/kg BW for the first 5 days of life; DOX, treated with doxycycline via drinking water at a dose rate of 50 mg/kg BW for the first 5 days of life.
IgA – immunoglobulin A, TLR-4 – Toll-like receptor 4, IL – 2-interleukin 2, IL-4 – interleukin 4, IL-6 – interleukin 6, IL-8 – interleukin 8, IL-12 – interleukin 12, IL-13 – interleukin 13, IL-1ß – interleukin 1ß, TNFα – tumor necrosis factor α, IFN-γ – interferon γ, NF-kB – nuclear factor kappa light chain, CRP– C-reactive protein.
Table 16.
Expression of genes in the blood of 7-day-old and 56-day-old turkeys
| Item | n | 7 days | 56 days | ||||
|---|---|---|---|---|---|---|---|
| IgY | IL-6 | IFN-γ | IgY | IL-6 | IFN-γ | ||
| Antibiotic1 | |||||||
| CON | 16 | 0.558 a | 0.330 b | 0.975 b | 0.586 a | 0.295 b | 0.989 a |
| ENR | 16 | 0.541 b | 0.349 a | 0.995 a | 0.575 b | 0.292 b | 0.975 b |
| DOX | 16 | 0.544 b | 0.342 ab | 0.985 ab | 0.577 b | 0.305 a | 0.983 ab |
| Monensin2 | |||||||
| − | 24 | 0.548 | 0.338 | 0.985 | 0.582 | 0.299 | 0.980 |
| + | 24 | 0.547 | 0.342 | 0.985 | 0.577 | 0.295 | 0.985 |
| Group | |||||||
| CON− | 8 | 0.557 | 0.326 | 0.972 | 0.590 | 0.299 | 0.987 |
| CON+ | 8 | 0.560 | 0.333 | 0.978 | 0.583 | 0.291 | 0.991 |
| ENR− | 8 | 0.542 | 0.347 | 0.997 | 0.576 | 0.296 | 0.973 |
| ENR+ | 8 | 0.539 | 0.351 | 0.994 | 0.575 | 0.288 | 0.977 |
| DOX− | 8 | 0.546 | 0.341 | 0.988 | 0.581 | 0.303 | 0.980 |
| DOX+ | 8 | 0.541 | 0.343 | 0.982 | 0.572 | 0.307 | 0.986 |
| SEM | 0.003 | 0.002 | 0.003 | 0.002 | 0.002 | 0.002 | |
| P value | |||||||
| antibiotic (A) | 0.010 | 0.002 | 0.009 | 0.011 | 0.003 | 0.025 | |
| monensin (M) | 0.729 | 0.320 | 0.887 | 0.075 | 0.167 | 0.291 | |
| A × M interaction | 0.787 | 0.897 | 0.640 | 0.491 | 0.174 | 0.963 | |
1 Treatment: CON, untreated control; MON, treated with monensin at a dose rate of 90 mg/kg feed for 56 days; ENR, treated with enrofloxacin via drinking water at a dose rate of 10 mg/kg BW for the first 5 days of life; DOX, treated with doxycycline via drinking water at a dose rate of 50 mg/kg BW for the first 5 days of life.
